Recombinant CCR2 (Plozalizumab Biosimilar) antibody

Catalog No. ABIN7597915

The Humanized Chimeric anti-CCR2 (Plozalizumab Biosimilar) antibody is suitable to detect CCR2 (Plozalizumab Biosimilar) in samples from Human.

Quick Overview for Recombinant CCR2 (Plozalizumab Biosimilar) antibody (ABIN7597915)

Target: CCR2 (Plozalizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This CCR2 (Plozalizumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-CCR2 (Plozalizumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Plozalizumab Biosimilar Antibody

Specificity: CCR2, CC-CKR-2, C-C chemokine receptor type 2, CCR-2, C-C CKR-2, MCP-1-R, CMKBR2, CD192, Monocyte chemoattractant protein 1 receptor

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for CCR2 (Plozalizumab Biosimilar)

Target: CCR2 (Plozalizumab Biosimilar)

Alternative Name: Plozalizumab Biosimilar

Target Type: Biosimilar

Background: CCR2, CC-CKR-2, C-C chemokine receptor type 2, CCR-2, C-C CKR-2, MCP-1-R, CMKBR2, CD192, Monocyte chemoattractant protein 1 receptor

UniProt: P41597

CAS-No: 1610761-46-0